Matthew McManus
Equibles does not estimate personal net worth.
Get an email with a short summary when BIO-TECHNE Corp publishes a filing, an earnings call transcript or a press release.
Get TECH alertsAbout Matthew McManus
The proxy statement of BIO-TECHNE Corp reports total compensation of $2,846,619 for Matthew McManus in fiscal 2025, including a base salary of $572,000. Disclosed compensation is on record for 4 fiscal years. BIO-TECHNE Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BIO-TECHNE Corp includes Charles Kummeth (CEO), James T. Hippel (CFO), Kim Kelderman (COO and Board Member) and 7 others.
Affiliation history
-
BIO-TECHNE Corp (TECH)
Proxy statement
Current
Company network
Leadership on record at BIO-TECHNE Corp
- Charles Kummeth CEO
- James T. Hippel CFO
- Kim Kelderman COO, Board Member
- Shane Bohnen General Counsel
- Alpna Seth Board Member
- Amy Herr Board Member
- Charles R. Kummeth Board Member
- Dr. Amy Herr Board Member
- Dr. Judith Klimovsky Board Member
- John L. Higgins Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BIO-TECHNE Corp (TECH) | President, Diagnostics and Spatial Biology | $572,000 | $2,846,619 |
| 2024 | BIO-TECHNE Corp (TECH) | President, Diagnostics and Genomics | $253,846 | $1,994,642 |
| 2023 | BIO-TECHNE Corp (TECH) | President, Diagnostics and Genomics | — | — |
| 2022 | BIO-TECHNE Corp (TECH) | President, Diagnostics and Genomics | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.